Charles Schwab’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.81M | Sell |
272,208
-60,904
| -18% | -$1.14M | ﹤0.01% | 2406 |
|
|
2026
Q1 | $5.82M | Sell |
333,112
-20,834
| -6% | -$413K | ﹤0.01% | 2338 |
|
|
2025
Q4 | $6.95M | Buy |
353,946
+65,867
| +23% | +$1.37M | ﹤0.01% | 2305 |
|
|
2025
Q3 | $7.94M | Buy |
288,079
+59,941
| +26% | +$1.84M | ﹤0.01% | 2217 |
|
|
2025
Q2 | $6.97M | Buy |
228,138
+54,141
| +31% | +$1.54M | ﹤0.01% | 2180 |
|
|
2025
Q1 | $4.69M | Buy |
173,997
+33,141
| +24% | +$1.05M | ﹤0.01% | 2299 |
|
|
2024
Q4 | $5.06M | Sell |
140,856
-38,166
| -21% | -$1.43M | ﹤0.01% | 2329 |
|
|
2024
Q3 | $6.79M | Sell |
179,022
-29,910
| -14% | -$1.23M | ﹤0.01% | 2214 |
|
|
2024
Q2 | $9.45M | Sell |
208,932
-29,774
| -12% | -$1.37M | ﹤0.01% | 2071 |
|
|
2024
Q1 | $11.6M | Buy |
238,706
+16,283
| +7% | +$797K | ﹤0.01% | 1917 |
|
|
2023
Q4 | $11.9M | Buy |
222,423
+8,536
| +4% | +$432K | ﹤0.01% | 1888 |
|
|
2023
Q3 | $12.5M | Buy |
213,887
+8,084
| +4% | +$505K | ﹤0.01% | 1795 |
|
|
2023
Q2 | $13M | Buy |
205,803
+3,665
| +2% | +$233K | ﹤0.01% | 1782 |
|
|
2023
Q1 | $12.7M | Buy |
202,138
+12,701
| +7% | +$758K | ﹤0.01% | 1753 |
|
|
2022
Q4 | $10.1M | Buy |
189,437
+20,539
| +12% | +$1.11M | ﹤0.01% | 1846 |
|
|
2022
Q3 | $9.47M | Buy |
168,898
+11,284
| +7% | +$746K | ﹤0.01% | 1873 |
|
|
2022
Q2 | $11.4M | Buy |
157,614
+14,212
| +10% | +$1.06M | ﹤0.01% | 1769 |
|
|
2022
Q1 | $11.4M | Buy |
143,402
+8,654
| +6% | +$780K | ﹤0.01% | 1882 |
|
|
2021
Q4 | $13.6M | Sell |
134,748
-2,311
| -2% | -$231K | ﹤0.01% | 1832 |
|
|
2021
Q3 | $12.6M | Buy |
137,059
+5,459
| +4% | +$525K | ﹤0.01% | 1870 |
|
|
2021
Q2 | $13.5M | Buy |
131,600
+6,251
| +5% | +$628K | ﹤0.01% | 1845 |
|
|
2021
Q1 | $12.2M | Sell |
125,349
-11,575
| -8% | -$1.05M | ﹤0.01% | 1842 |
|
|
2020
Q4 | $10.6M | Buy |
136,924
+3,909
| +3% | +$302K | ﹤0.01% | 1839 |
|
|
2020
Q3 | $9.8M | Sell |
133,015
-3,299
| -2% | -$265K | ﹤0.01% | 1710 |
|
|
2020
Q2 | $10M | Sell |
136,314
-1,747
| -1% | -$137K | ﹤0.01% | 1654 |
|
|
2020
Q1 | $7.97M | Buy |
138,061
+15,249
| +12% | +$1.06M | ﹤0.01% | 1588 |
|
|
2019
Q4 | $9.65M | Buy |
122,812
+6,079
| +5% | +$448K | 0.01% | 1686 |
|
|
2019
Q3 | $7.98M | Sell |
116,733
-64,238
| -35% | -$4.31M | ﹤0.01% | 1731 |
|
|
2019
Q2 | $14.4M | Buy |
180,971
+4,254
| +2% | +$337K | 0.01% | 1375 |
|
|
2019
Q1 | $14.8M | Buy |
176,717
+42,436
| +32% | +$4.43M | 0.01% | 1315 |
|
|
2018
Q4 | $15.8M | Buy |
134,281
+2,983
| +2% | +$345K | 0.01% | 1139 |
|
|
2018
Q3 | $15.8M | Buy |
131,298
+3,379
| +3% | +$419K | 0.01% | 1319 |
|
|
2018
Q2 | $14.8M | Sell |
127,919
-272
| -0.2% | -$29.8K | 0.01% | 1312 |
|
|
2018
Q1 | $11M | Buy |
128,191
+44,707
| +54% | +$3.46M | 0.01% | 1424 |
|
|
2017
Q4 | $6.18M | Sell |
83,484
-1,373
| -2% | -$91.8K | ﹤0.01% | 1803 |
|
|
2017
Q3 | $4.9M | Sell |
84,857
-7,204
| -8% | -$426K | ﹤0.01% | 1891 |
|
|
2017
Q2 | $5.9M | Sell |
92,061
-32,900
| -26% | -$2.03M | 0.01% | 1713 |
|
|
2017
Q1 | $7.2M | Buy |
124,961
+4,297
| +4% | +$257K | 0.01% | 1544 |
|
|
2016
Q4 | $7.38M | Buy |
120,664
+52,198
| +76% | +$3.4M | 0.01% | 1475 |
|
|
2016
Q3 | $4.74M | Buy |
68,466
+3,380
| +5% | +$223K | 0.01% | 1690 |
|
|
2016
Q2 | $3.63M | Sell |
65,086
-10,526
| -14% | -$635K | ﹤0.01% | 1765 |
|
|
2016
Q1 | $4.59M | Sell |
75,612
-3,170
| -4% | -$187K | 0.01% | 1564 |
|
|
2015
Q4 | $5.03M | Sell |
78,782
-14,694
| -16% | -$953K | 0.01% | 1513 |
|
|
2015
Q3 | $6.26M | Buy |
93,476
+4,266
| +5% | +$302K | 0.01% | 1323 |
|
|
2015
Q2 | $6.1M | Buy |
89,210
+3,384
| +4% | +$215K | 0.01% | 1423 |
|
|
2015
Q1 | $4.77M | Buy |
85,826
+11,122
| +15% | +$570K | 0.01% | 1539 |
|
|
2014
Q4 | $3.83M | Buy |
74,704
+26,266
| +54% | +$1.29M | 0.01% | 1633 |
|
|
2014
Q3 | $1.78M | Buy |
48,438
+6,078
| +14% | +$219K | ﹤0.01% | 2025 |
|
|
2014
Q2 | $1.66M | Buy |
42,360
+13,096
| +45% | +$486K | ﹤0.01% | 2081 |
|
|
2014
Q1 | $1.1M | Buy |
29,264
+840
| +3% | +$29.3K | ﹤0.01% | 2238 |
|
|
2013
Q4 | $1.07M | Buy |
28,424
+1,008
| +4% | +$38.6K | ﹤0.01% | 2233 |
|
|
2013
Q3 | $1.22M | Buy |
27,416
+1,358
| +5% | +$54.5K | ﹤0.01% | 2125 |
|
|
2013
Q2 | $950K | Buy |
+26,058
| New | +$792K | ﹤0.01% | 2191 |
|
Other funds holding USNA
NCM
Charles Schwab's USNA Position: Q2 2026 in Review
Charles Schwab reduced its Usana Health Sciences (USNA) stake by 18% in Q2 2026, selling an estimated $1.14M and leaving 272,208 shares worth $5.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2406.
Charles Schwab first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.8M in Q3 2018. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- Charles Schwab held 272,208 shares of Usana Health Sciences worth $5.81M as of Q2 2026.
- Charles Schwab sold 60,904 Usana Health Sciences shares in Q2 2026, an estimated $1.14M.
- Usana Health Sciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2406 holding.
- Charles Schwab first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Usana Health Sciences position peaked at $15.8M in Q3 2018.
- 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.